ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products.
Financial Results:
- ERIS Lifesciences Ltd reported Revenues for Q1FY24 of ₹467.00 Crores up from ₹399.00 Crore year on year, a rise of 17.04%.
- Total Expenses for Q1FY24 of ₹355.00 Crores up from ₹299.00 Crores year on year, a rise of 18.73%.
- Consolidated Net Profit of ₹94.00 Crores up 1.08% from ₹93.00 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹6.98, up 0.29% from ₹6.96 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.